FEMY Historical PE Ratio Notes

— Femasys Inc. (ticker: FEMY) is a medical technology company focused on developing innovative products in women’s reproductive health, including fertility, infertility solutions, & permanent contraception. Their leading products, FemVue™ for diagnostic imaging & FemBloc™ for non-surgical sterilization, address large market needs, but as a growth-stage company Femasys has historically generated little to no revenue while incurring significant research & development costs. As you research FEMY’s historical PE ratio, it is important to note that companies like Femasys, typically in early commercialization or pre-commercial phases, often report negative earnings per share (EPS), making the PE ratio either not meaningful (N/M), negative, or highly volatile over time. Periods where you see no PE displayed often coincide with ongoing net losses. Only as (or if) the company transitions to consistent profitability—thanks to successful product launches & market adoption—would the PE ratio become a reliable valuation metric. Therefore, volatility or absence of a historical PE ratio is common for developmental healthcare firms like FEMY, reflecting their ongoing investment phase rather than mature earnings power.

On this page we presented the FEMY Historical PE Ratio information for Femasys' stock. The average FEMY historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FEMY historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FEMY historical PE result, against the recent PE: when this page was posted on 8/20/2026, the most recent closing price for FEMY had been 2.73, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on FEMY or any other given stock, valuation analysis for FEMY can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Femasys PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for FEMY. Thanks for visiting, and the next time you need to research FEMY Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.